Property | Value |
?:abstract
|
-
Evidence suggests that asymptomatic and mild SARS-CoV-2 infections comprise > 95% of all cases. Developing a test that indicates past infection and possible immunity against the virus is important. We administered 244 antibody tests to three groups of high-risk population. The test consisted of an IgG component and an IgM component. The overall IgM/IgG positivity for patients with none, mild, moderate, and severe symptoms were 21.1%, 21.8%, 14.2%, and 26.9%, respectively. Those with moderate or severe symptoms were no more or less likely to have positive antibody tests than those with no or mild symptoms.
|
is
?:annotates
of
|
|
?:creator
|
|
?:doi
|
-
10.1007/s10096-020-04111-3
|
?:doi
|
|
?:journal
|
-
Eur_J_Clin_Microbiol_Infect_Dis
|
?:license
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/b80b07cfd66d036a26c4fd6f43ba0a5ea133649d.json
|
?:pmc_json_files
|
-
document_parses/pmc_json/PMC7688294.xml.json
|
?:pmcid
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
?:sha_id
|
|
?:source
|
|
?:title
|
-
COVID-19 IgG/IgM antibody testing in Los Angeles County, California
|
?:type
|
|
?:year
|
|